Assumed costs of ART delivery.

#ARV and ART cost assumptions are based on country-specific estimates of ARV and service delivery cost and a fixed cost for laboratory and end-of-life treatment of opportunistic infections. The shown average ‘Total’ is weighted across Global Fund-supported AIDS programs according to their number of patients at end-2009. The shown weighted average costs of the individual components do not add up to the weighted average total cost per patient, because of considerable variation among countries in the cost of ARVs and treatment delivery.